Get GLP-1 Prescription Online: Process, Eligibility & Cost

You are researching GLP-1 medications for weight loss. You have already decided you want to try them. But the idea of calling your provider’s office, scheduling an appointment weeks out, sitting in a waiting room full of sick people to ask for a weight loss prescription sounds bureaucratic and slow.

The good news: you do not have to do that. You can get evaluated by a licensed provider entirely online, in about 10 minutes, without ever leaving your house. Here is how it works, what you will pay, who actually qualifies, and what happens after you submit your information.

The 4-step online process: from intake to your door

The entire process is designed to be straightforward and transparent. Here is exactly what happens:

State-specific requirement: Residents of Arkansas, DC, Delaware, Mississippi, New Mexico, Rhode Island, and West Virginia are required by state law^[3] to complete a live video consultation with a provider before a prescription can be written. This is scheduled at no additional cost and typically takes 10-15 minutes.

Who actually qualifies for an online GLP-1 prescription

Not everyone qualifies, and that is intentional. A licensed provider makes the final determination, not an algorithm. Here are the standard criteria:

BMI thresholds

• BMI of 30 or higher^[1], OR
• BMI of 27 or higher with a weight-related health condition^[1]

Weight-related health conditions include type 2 diabetes, high blood pressure, high cholesterol, heart disease, sleep apnea, and other metabolic conditions.

Important: the BMI threshold is not automatic

Meeting the BMI requirement is necessary but not sufficient. The provider evaluates your complete health history. Some patients who meet the BMI threshold do not qualify due to medical history or current medications. This is appropriate medical practice.

Medical history that makes GLP-1 inappropriate

Certain conditions contraindicate GLP-1 therapy:

• Personal or family history of medullary thyroid cancer^[2]
• History of MEN2 syndrome (multiple endocrine neoplasia type 2)^[2]
• History of pancreatitis^[2]
• Severe kidney disease^[2]
• History of severe eating disorders (risk of restriction combined with medication)

Your provider evaluates your full medical context. If you have any of these conditions or are uncertain whether you qualify, the assessment will reveal it.

Age requirement

You must be 18 to 76 years old.

What qualifies you: detailed breakdown

Your provider reviews several factors:

Your current health status:

• Type 2 diabetes (makes you eligible regardless of BMI)
• High blood pressure (hypertension)
• High cholesterol (dyslipidemia)
• Heart disease or cardiovascular disease
• Obstructive sleep apnea
• Other metabolic conditions

Your medications:

• The provider checks for interactions between GLP-1 medications and your current prescriptions
• If you take medications that contraindicate GLP-1 therapy, your provider will advise you

Your weight loss history:

• Previous attempts at calorie restriction, exercise, or other medications
• Your provider does not judge your history; they understand the biology of weight loss resistance
• Your experience informs the clinical decision

Your readiness:

• Your provider determines whether you understand what the medication does and does not do
• GLP-1 medications reduce appetite^[5][6]; they do not guarantee a specific weight loss outcome
• You must be willing to make nutrition and fitness adjustments alongside medication

What is included in the program: all-inclusive pricing

One monthly fee covers everything. No hidden charges. Here is what you get:

What “all-inclusive” means

Your monthly fee covers:

• Medication, prepared by a US-based compounding pharmacy and shipped to your door
• Provider care, including your initial evaluation, monthly prescription renewals, and ongoing clinical oversight
• Lab work, ordered by your provider as clinically appropriate (Quest or Labcorp)
• Medical weight loss coaching, to support habit-building and sustainable progress
• 24/7 message support with your care team for questions about dosing, side effects, or your treatment
• Free shipping, with discreet, temperature-controlled delivery

You will not receive surprise bills. There are no separate lab fees. No consultation charges. No shipping costs added at checkout. The price you see is the price you pay.

Payment options

• Visa, Mastercard, Discover
• FSA and HSA cards (GLP-1 medications prescribed for weight management are generally FSA/HSA-eligible)
• American Express is not currently accepted
• Cancel anytime

Why telehealth vs. an in-person provider visit

You might wonder whether an online evaluation is as thorough as an in-person appointment. It is, because the clinical process is the same either way.

The clinical reality

A licensed provider needs your health history to make a prescribing decision. Whether they get that information from an in-person office visit or a detailed online intake form does not change the quality of that evaluation. In fact, the online process often captures more detail because the form is comprehensive.

The practical advantages of telehealth

• No waiting rooms and no scheduling delays. You can submit your intake form at midnight on a Tuesday if you want. Your provider reviews it within 24-48 hours, not weeks.
• No insurance prerequisite. In-person obesity medicine specialists often require insurance. Telehealth programs accept cash-pay patients directly.
• Faster access. The average wait to see an in-person obesity medicine specialist in major metro areas is 3-6 months. Most Transformation Health patients get their medication within a week.
• Same clinical oversight. Whether your provider sees you in an office or reviews your health history online, they are making the same clinical evaluation. The insurance model has not changed.

For most patients, telehealth provides equivalent care

If you have complex comorbidities requiring frequent in-person monitoring (such as active cardiac disease or uncontrolled diabetes), your provider may recommend in-person care. For most patients without active medical crises, telehealth provides full clinical access to the medical decision-making you need.

Safety considerations and important disclosures

Compounded medications are not the same as brand-name FDA-approved products. Here is what you need to know:

Compounded medications and FDA approval

Compounded medications are NOT FDA-approved. They are not reviewed by the FDA for safety, efficacy, or quality before being dispensed.^[4] This is a critical distinction from FDA-approved branded GLP-1 medications.

Compounded semaglutide and tirzepatide are prepared by US-based, state-licensed compounding pharmacies. These pharmacies operate under federal and state regulations (503A/503B compounding rules)^[4] and must follow good manufacturing practices. But the FDA does not independently evaluate each batch for safety, efficacy, or quality.

This means you should understand that compounded and brand-name medications are different products, even though they contain the same active ingredients.

Monitoring and lab work

Your provider includes lab work in your program because monitoring is essential. Lab work allows your provider to evaluate your metabolic health, liver and kidney function, and other markers relevant to GLP-1 therapy. This monitoring happens throughout your treatment, not just at the start.

If your provider identifies any concerns in your labs, they adjust your treatment plan. This is standard medical practice for any medication therapy.

Your provider makes adjustments as needed

Your treatment is not static. Your provider monitors your progress, your side effects, and your overall health. If the current dose is not working or if you experience side effects, your provider can adjust your program. If a different medication is more appropriate after reassessing your situation, your provider can recommend that change.

What to have ready for your online assessment

When you complete your intake form, have the following information available:

Your measurements:

• Current weight
• Height (for BMI calculation)

Your medications:

• A list of all current prescriptions
• Over-the-counter medications you take regularly
• Any supplements or vitamins

Your medical history:

• Any history of thyroid disease, thyroid cancer, or thyroid nodules
• Any history of pancreatitis (inflammation of the pancreas)
• Any history of gallbladder disease
• Any history of kidney disease or kidney function issues
• Any history of eating disorders
• Any diagnosis of type 2 diabetes, prediabetes, or other blood sugar issues
• Any history of high blood pressure, high cholesterol, or heart disease
• Any sleep disorders, especially sleep apnea
• Any other chronic health conditions

Recent lab results (optional but helpful):

• If you have had recent blood work, fasting glucose, or metabolic panel results, having those available is helpful (but not required to start)

You do not need to memorize all of this. The form will prompt you for each piece of information. If you are unsure about anything, leave it blank and answer what you can.

The bottom line

Getting a GLP-1 prescription online is straightforward if you qualify. A licensed provider makes a real clinical evaluation of your health history. If they determine the medication is appropriate, your prescription is filled by a licensed compounding pharmacy and shipped to your door. You get ongoing provider support, lab work, and coaching as part of your monthly fee.

The process is designed to be transparent, affordable, and focused on your actual medical care, not on pushing volume.

Citations

[1] National Institute of Diabetes and Digestive and Kidney Diseases. “Prescription Medications to Treat Overweight and Obesity.” National Institutes of Health. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

[2] U.S. Food and Drug Administration. “Prescribing Information for semaglutide for chronic weight management.” 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf

[3] State telehealth regulatory requirements for live consultation prior to prescription issuance. Applicable in AR, DC, DE, MS, NM, RI, and WV.

[4] U.S. Food and Drug Administration. “Compounding and FDA: Questions and Answers.” FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

[5] Wilding JPH, Batterham RL, Calanna S, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/

[6] Jastreboff AM, Aroda VR, Kushner RF, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine. 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/